PubMed=15645427; DOI=10.1002/ijc.20684
Chan K.Y.-Y., Wong N., Lai P.B.-S., Squire J.A., Macgregor P.F., Beheshti B., Albert M., To K.-F., Johnson P.J.
Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.
Int. J. Cancer 114:902-908(2005)

PubMed=15709204; DOI=10.1158/1078-0432.1319.11.3
Wong N., Chan K.Y.-Y., Macgregor P.F., Lai P.B.-S., Squire J.A., Beheshti B., Albert M., Leung T.W.-T.
Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells.
Clin. Cancer Res. 11:1319-1326(2005)

PubMed=15765123; DOI=10.1038/labinvest.3700254
Pang E., Hu Y., Chan K.Y.-Y., Lai P.B.-S., Squire J.A., Macgregor P.F., Beheshti B., Albert M., Leung T.W.-T., Wong N.
Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells.
Lab. Invest. 85:664-674(2005)

PubMed=19003983; DOI=10.1002/ijc.23968
Wong N., Yeo W., Wong W.-L., Wong N.L.-Y., Chan K.Y.-Y., Mo F.K.-F., Koh J., Chan S.L., Chan A.T.-C., Lai P.B.-S., Ching A.K.-K., Tong J.H.-M., Ng H.-K., Johnson P.J., To K.-F.
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
Int. J. Cancer 124:644-652(2009)